registered direct offering

BOSTON, June 18, 2026 CervoMed Inc., a clinical-stage biotechnology company focused on developing therapies for age-related neurological disorders, has...

NEW HAVEN, Connecticut — March 10, 2026 Biotechnology company BioXcel Therapeutics Inc. has announced a registered direct offering expected...